Patent assignee · US · COMPANY

Prometheus Laboratories Inc.

🏢 View company profile →
21Patents
11Active
21Granted
46Portfolio score

Filing activity: Apr 11, 1997 → Sep 1, 2023 · 6 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8163499B2 Drug selection for breast cancer therapy using antibody-based arrays Physics 36 Active
US6986995B2 Methods of diagnosing liver fibrosis Emerging Cross-Sectional Technologies 29 Expired
US6218129A Inflammatory bowel disease first step assay system Physics 29 Expired
US5932429A Methods of diagnosing clinical subtypes of crohn's disease Emerging Cross-Sectional Technologies 20 Expired
US7670764B2 Methods of diagnosing tissue fibrosis Physics 14 Expired
US6183951A Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapy Physics 13 Expired
US7759079B2 Methods of diagnosing inflammatory bowel disease Physics 13 Expired
US7908091B2 Methods of predicting and monitoring tyrosine kinase inhibitor therapy Physics 11 Active
US6576438B2 Method of determining thiopurine methyltransferase activity Physics 8 Expired
US7873479B2 Methods of diagnosing inflammatory bowel disease Emerging Cross-Sectional Technologies 6 Active
US6921667B2 Methods for direct detection of individual methotrexate metabolites Emerging Cross-Sectional Technologies 4 Expired
US7582282B2 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics Emerging Cross-Sectional Technologies 2 Expired
US11160863B2 Methods of disease activity profiling for personalized therapy management Emerging Cross-Sectional Technologies 2 Active
US7695908B2 Methods for predicting methotrexate polyglutamate levels using pharmacogenetics Chemistry; Metallurgy 2 Active
US8114616B2 Methods for diagnosing irritable bowel syndrome Emerging Cross-Sectional Technologies 2 Active
US7943328B1 Method and system for assisting in diagnosing irritable bowel syndrome Physics 2 Active
US11846642B2 Indirect homogeneous mobility shift assays for the detection of biologics in patient samples Physics 0 Active
US12422432B2 Methods for assessing mucosal healing in inflammatory bowel disease patients Emerging Cross-Sectional Technologies 0 Active
US11435347B2 Methods for prediction of anti-TNF α drug levels and autoantibody formation Physics 0 Active
US11796541B2 Methods for assessing mucosal healing in ulcerative colitis disease patients Emerging Cross-Sectional Technologies 0 Active
US7138250B2 Method of determining thiopurine methyltransferase activity Physics 0 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.